Compound veterinary medicine preparation for treating avian enteritis type colibacillosis

A technology for colibacillosis and avian enteritis, applied in the field of compound veterinary drug preparations, can solve problems such as decreased curative effect, achieve good therapeutic effect, prevent secondary infection, and be difficult to produce drug resistance.

Inactive Publication Date: 2013-02-13
HEZE PUEN PHARMA
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to its extensive use, a certain degree of drug resi...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] 100g neomycin sulfate 2.75g (based on effective content) Lactic acid TMP 0.69g (based on effective content) Glutamine 10g (based on effective content) glucose Add to 100g

[0013] The preparation method and steps: crush and sieve each component respectively, accurately weigh according to the required ratio, mix for 25 minutes, semi-finished product quality inspection, sub-packaging, packaging, and finished product quality inspection.

[0014] When in use, 100 g of this preparation is mixed with 100 L of water for the treatment of clinical poultry enteritis colibacillosis. Continuous use for 4 days is a course of treatment, and the drug withdrawal period is 5 days.

[0015] The effective rate of the preparation for the treatment of poultry enteritis colibacillosis is 62%, and the cure rate is 50%. Compared with 2.75% neomycin sulfate soluble powder, the effective rate and cure rate are respectively higher by 18% and 16%. ideal. ...

Embodiment 2

[0017] 100g neomycin sulfate 3g (based on effective content) Lactic acid TMP 0.75g (based on effective content) Glutamine 10g (based on effective content) glucose Add to 100g

[0018] The preparation method and steps: crush and sieve each component respectively, accurately weigh according to the required ratio, mix for 25 minutes, semi-finished product quality inspection, sub-packaging, packaging, and finished product quality inspection.

[0019] When in use, 100 g of this preparation is mixed with 100 L of water for the treatment of clinical poultry enteritis colibacillosis. Continuous use for 4 days is a course of treatment, and the drug withdrawal period is 5 days.

[0020] The effective rate and cure rate of this preparation in treating poultry enteritis colibacillosis are 82% and 71%, respectively. .

Embodiment 3

[0022] 100g neomycin sulfate 3.25g (based on effective content) Lactic acid TMP 0.81g (based on effective content) Glutamine 10g (based on effective content) glucose Add to 100g

[0023] The preparation method and steps: crush and sieve each component respectively, accurately weigh according to the required ratio, mix for 25 minutes, semi-finished product quality inspection, sub-packaging, packaging, and finished product quality inspection.

[0024] When in use, 100 g of this preparation is mixed with 100 L of water for the treatment of clinical poultry enteritis colibacillosis. Continuous use for 4 days is a course of treatment, and the drug withdrawal period is 5 days.

[0025] The effective rate and cure rate of this preparation in treating poultry enteritis colibacillosis are 93% and 82% respectively. ideal.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to a compound veterinary medicine preparation for treating avian enteritis type colibacillosis in veterinary medicine. The preparation consists of three main medicinal components and an adjuvant; three main medicinal components include 3.25%W/W of neomycin sulfate, 0.81%W/W of lactic acid TMP (Trimethoprim) and 10%W/W of glutamine; and the adjuvant includes 85.94%W/W of glucose. The veterinary medicine preparation is utilized to treat the avian enteritis type colibacillosis. A processing technology of the composition is as follows: respectively grinding, screening and accurately weighing the components according to the necessary ratio, mixing for 25 min, and performing semi-finished product quality control, split charging, packaging and finished product quality control to obtain the composition. An application method is as follows: drinking the water in 1% level of the composition, and a course of treatment lasts for 4 days. The compound veterinary medicine preparation provided by the invention is remarkable in efficacy of avian enteritis type colibacillosis, low in drug resistance, safe and low toxicity, thereby having good popularization and application value.

Description

technical field [0001] The invention relates to a compound veterinary drug preparation and a preparation process for treating poultry enteritis colibacillosis. Background technique [0002] Enteritic colibacillosis is one of the most common and serious diseases in poultry farming. In veterinary clinics, after poultry is infected with enteritis colibacillosis, it often manifests as diarrhea, loss of appetite, rough feathers, indigestion of feed, slow growth, gradual increase in elimination rate, and reduced production performance, causing serious damage to the poultry breeding industry. Economic losses. And after being infected with this disease, it will cause poultry resistance to decrease, easy to secondary coccidiosis, clostridial disease, etc., make the disease worse, the treatment effect is not ideal, the mortality rate increases, sometimes as high as more than 50%, and the economic loss is even more serious. [0003] The more commonly used method to control enteritis ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7036A61K31/505A61K31/198A61P31/04A61P1/04
Inventor 王彬
Owner HEZE PUEN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap